Public consultation for products subsidised under the NDSS 14 June 2023 The Department of Health and Aged Care is currently conducting a public consultation process to gather feedback on the current range of products subsidised under the NDSS. The aim is to ensure that the products offered continue to meet the needs of people with diabetes. To assist in this process they are seeking feedback from people living with diabetes registered on the NDSS. There is an opportunity to provide feedback about the current range of products and what’s important in the future. For more information or to access the online survey go to: consultations.health.gov.au/technology-assessment-access-division/national-diabetes-services-scheme-ndss-products/. Written submissions can be sent to the following address: [email protected] and must be received by the time the survey closes on 2 July 2023.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading
